This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gillim-Ross, L. Articles by Subbarao, K. Search for Related Content PubMed PubMed Citation Articles by Gillim-Ross, L. Articles by Subbarao, K.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, October 2006, p. 614-636, Vol. 19, No. 4
0893-8512/06/$08.00+0     doi:10.1128/CMR.00005-06

Emerging Respiratory Viruses: Challenges and Vaccine Strategies

Laura Gillim-Ross and Kanta Subbarao^*

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892

The current threat of avian influenza to the human population, the potential for the reemergence of severe acute respiratory syndrome (SARS)-associated coronavirus, and the identification of multiple novel respiratory viruses underline the necessity for the development of therapeutic and preventive strategies to combat viral infection. Vaccine development is a key component in the prevention of widespread viral infection and in the reduction of morbidity and mortality associated with many viral infections. In this review we describe the different approaches currently being evaluated in the development of vaccines against SARS-associated coronavirus and avian influenza viruses and also highlight the many obstacles encountered in the development of these vaccines. Lessons learned from current vaccine studies, coupled with our increasing knowledge of the host and viral factors involved in viral pathogenesis, will help to increase the speed with which efficacious vaccines targeting newly emerging viral pathogens can be developed.

---

* Corresponding author. Mailing address: 50 South Drive, MSC 8007, Bethesda, MD 20892. Phone: (301) 451-3839. Fax: (301) 496-8312. E-mail: ksubbarao{at}niaid.nih.gov.

---

Clinical Microbiology Reviews, October 2006, p. 614-636, Vol. 19, No. 4
0893-8512/06/$08.00+0     doi:10.1128/CMR.00005-06

This article has been cited by other articles:

• Quan, F. S., Yoo, D.-G., Song, J.-M., Clements, J. D., Compans, R. W., Kang, S.-M. (2009). Kinetics of Immune Responses to Influenza Virus-Like Particles and Dose-Dependence of Protection with a Single Vaccination. J. Virol. 83: 4489-4497 [Abstract] [Full Text]  
• Mahony, J. B. (2008). Detection of Respiratory Viruses by Molecular Methods. Clin. Microbiol. Rev. 21: 716-747 [Abstract] [Full Text]  
• Parrish, C. R., Holmes, E. C., Morens, D. M., Park, E.-C., Burke, D. S., Calisher, C. H., Laughlin, C. A., Saif, L. J., Daszak, P. (2008). Cross-Species Virus Transmission and the Emergence of New Epidemic Diseases. Microbiol. Mol. Biol. Rev. 72: 457-470 [Abstract] [Full Text]  
• Marshall, D. J., Reisdorf, E., Harms, G., Beaty, E., Moser, M. J., Lee, W.-M., Gern, J. E., Nolte, F. S., Shult, P., Prudent, J. R. (2007). Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting. J. Clin. Microbiol. 45: 3875-3882 [Abstract] [Full Text]  
• Richards, K. A., Chaves, F. A., Krafcik, F. R., Topham, D. J., Lazarski, C. A., Sant, A. J. (2007). Direct Ex Vivo Analyses of HLA-DR1 Transgenic Mice Reveal an Exceptionally Broad Pattern of Immunodominance in the Primary HLA-DR1-Restricted CD4 T-Cell Response to Influenza Virus Hemagglutinin. J. Virol. 81: 7608-7619 [Abstract] [Full Text]  
• Peiris, J. S. M., de Jong, M. D., Guan, Y. (2007). Avian Influenza Virus (H5N1): a Threat to Human Health. Clin. Microbiol. Rev. 20: 243-267 [Abstract] [Full Text]